List of largest biomedical companies by market capitalization: Difference between revisions
| Line 8: | Line 8: | ||
The following is a list of the '''top 100 companies''' ranked by revenue.<ref name=MedAdNews2007>''Top 100 biotechnology companies'', [[MedAdNews]], June 2007</ref> The first nine companies qualify for the list of the [[top 50 pharmaceutical companies]]. |
The following is a list of the '''top 100 companies''' ranked by revenue.<ref name=MedAdNews2007>''Top 100 biotechnology companies'', [[MedAdNews]], June 2007</ref> The first nine companies qualify for the list of the [[top 50 pharmaceutical companies]]. |
||
| ⚫ | |||
{|class="sortable wikitable" |
|||
!Rank 2006 |
|||
!Company |
|||
!Country |
|||
!width=100|Revenue in 2006 <small>(USD millions)</small> |
|||
!width=100|R&D in 2006 <small>(USD millions)</small> |
|||
!width=100|Net income/ (loss) in 2006 <small>(USD millions)</small> |
|||
!width=100|Employees in 2006 |
|||
| ⚫ | |||
|align=center|1||[[Amgen]]||USA||align=right|14,268.0||align=right|3,366.0||align=right|2,950.0||align=right|20,100 |
|||
|- |
|||
|align=center|2||[[Genentech]]||USA||align=right|9,284.0||align=right|1,773.0||align=right|2,113.0||align=right|10,533 |
|||
|- |
|||
|align=center|3||[[Genzyme]]||USA||align=right|3,187.0||align=right|650.0||align=right|(16.8)||align=right|9,000+ |
|||
|- |
|||
|align=center|4||[[UCB (company)|UCB]]||Belgium||align=right|3,169.6||align=right|772.6||align=right|461.1||align=right|8,477 |
|||
|- |
|||
|align=center|5||[[Gilead Sciences]]||USA||align=right|3,026.1||align=right|383.9||align=right|(1,190.0)||align=right|7,575 |
|||
|- |
|||
|align=center|6||[[Serono]]||Switzerland||align=right|2,804.9||align=right|560.5||align=right|735.4||align=right|4,775 |
|||
|- |
|||
|align=center|7||[[Biogen Idec]]||USA||align=right|2,683.0||align=right|718.4||align=right|217.5||align=right|3,750 |
|||
|- |
|||
|align=center|8||[[CSL Limited|CSL]]||Australia||align=right|2,148.3||align=right|119.1||align=right|86.8||align=right|2,895 |
|||
|- |
|||
|align=center|9||[[Cephalon]]||USA||align=right|1,764.1||align=right|403.4||align=right|144.8||align=right|2,515 |
|||
|- |
|||
|align=center|10||[[MedImmune]]||USA||align=right|1,276.8||align=right|448.9||align=right|48.7||align=right|2,359 |
|||
|- |
|||
|align=center|11||[[Celgene]]||USA||align=right|898.9||align=right|258.6||align=right|69.0||align=right|1,864 |
|||
|- |
|||
|align=center|12||[[Abraxis BioScience]]||USA||align=right|765.5||align=right|96.9||align=right|(46.9)||align=right|1,734 |
|||
|- |
|||
|align=center|13||[[Actelion]]||Switzerland||align=right|754.6||align=right|169.0||align=right|192.4||align=right|1,550 |
|align=center|13||[[Actelion]]||Switzerland||align=right|754.6||align=right|169.0||align=right|192.4||align=right|1,550 |
||
|- |
|- |
||
Revision as of 05:52, 30 September 2008
A "biotechnology company" is a company whose products or services primarily use biotechnology methods for their production, design or delivery.[citation needed] Examining the list of the top 100 such companies, below, shows that many have negative revenue. This is consistent with the notion that only one in ten biotechnology companies were considered profitable in mid-2005.[1]
Top 100 Biotechnology Companies
The following is a list of the top 100 companies ranked by revenue.[2] The first nine companies qualify for the list of the top 50 pharmaceutical companies.
| |align=center|13||Actelion||Switzerland||align=right|754.6||align=right|169.0||align=right|192.4||align=right|1,550 |- |align=center|14||ImClone Systems||USA||align=right|677.8||align=right|112.1||align=right|370.7||align=right|1,287 |- |align=center|16||Amylin Pharmaceuticals||USA||align=right|510.9||align=right|222.1||align=right|(218.9)||align=right|1,100 |- |align=center|17||Millennium Pharmaceuticals||USA||align=right|486.8||align=right|318.2||align=right|(44.0)||align=right|1,073 |- |align=center|18||PDL BioPharma||USA||align=right|414.8||align=right|260.7||align=right|(130.0)||align=right|993 |- |align=center|19||OSI Pharmaceuticals||USA||align=right|375.7||align=right|176.7||align=right|(582.2)||align=right|962 |- |align=center|20||MGI Pharma||USA||align=right|342.8||align=right|100.1||align=right|(40.2)||align=right|947 |- |align=center|21||Pharmion||USA||align=right|238.6||align=right|70.1||align=right|(91.0)||align=right|793 |- |align=center|22||Nektar Therapeutics||USA||align=right|217.7||align=right|149.4||align=right|(154.8)||align=right|770 |- |align=center|23||Vertex Pharmaceuticals||USA||align=right|216.4||align=right|371.7||align=right|(206.9)||align=right|760 |- |align=center|24||Biocon||India||align=right|200.3||align=right|30.5||align=right|43.5||align=right|1,838 |- |align=center|25||Cubist Pharmaceuticals||USA||align=right|194.7||align=right|57.4||align=right|(0.4)||align=right|746 |- |align=center|26||Enzon Pharmaceuticals||USA||align=right|185.7||align=right|43.5||align=right|21.3||align=right|722 |- |align=center|27||QLT||Canada||align=right|175.1||align=right|56.4||align=right|(101.6)||align=right|653 |- |align=center|28||ViroPharma||USA||align=right|167.2||align=right|19.2||align=right|66.7||align=right|651 |- |align=center|29||Alkermes||USA||align=right|166.6||align=right|89.1||align=right|3.8||align=right|617 |- |align=center|30||Crucell||Netherlands||align=right|165.3||align=right|84.9||align=right|(110.0)||align=right|611 |- |align=center|31||United Therapeutics||USA||align=right|159.6||align=right|57.6||align=right|74.0||align=right|585 |- |align=center|32||LifeCell||USA||align=right|141.7||align=right|16.5||align=right|20.5||align=right|573 |- |align=center|33||Ligand Pharmaceuticals||USA||align=right|141.0||align=right|41.9||align=right|(31.7)||align=right|540 |- |align=center|34||Myriad Genetics||USA||align=right|114.3||align=right|83.8||align=right|(38.2)||align=right|511 |- |align=center|35||Exelixis||USA||align=right|98.7||align=right|185.5||align=right|(101.5)||align=right|500 |- |align=center|36||Cangene||Canada||align=right|96.8||align=right|22.1||align=right|11.6||align=right|498 |- |align=center|37||InterMune||USA||align=right|90.8||align=right|103.8||align=right|(107.2)||align=right|492 |- |align=center|38||Nabi Biopharmaceuticals||USA||align=right|89.9||align=right|37.6||align=right|(58.7)||align=right|487 |- |align=center|39||BioMarin Pharmaceutical||USA||align=right|84.2||align=right|66.7||align=right|(28.5)||align=right|417 |- |align=center|40||Lexicon Pharmaceuticals||USA||align=right|72.8||align=right|106.7||align=right|(54.3)||align=right|410 |- |align=center|41||Progenics Pharmaceuticals||USA||align=right|69.9||align=right|61.7||align=right|(21.6)||align=right|410 |- |align=center|42||Innogenetics||Belgium||align=right|67.5||align=right|32.1||align=right|(31.5)||align=right|371 |- |align=center|43||Idenix Pharmaceuticals||USA||align=right|67.4||align=right|96.1||align=right|(75.1)||align=right|359 |- |align=center|44||MorphoSys||Germany||align=right|66.6||align=right|21.9||align=right|7.6||align=right|336 |- |align=center|45||Omrix Biopharmaceuticals||USA||align=right|63.8||align=right|3.4||align=right|23.1||align=right|335 |- |align=center|46||Regeneron Pharmaceuticals||USA||align=right|63.4||align=right|137.1||align=right|(102.3)||align=right|323 |- |align=center|47||Acambis||UK||align=right|57.0||align=right|68.2||align=right|(30.4)||align=right|285 |- |align=center|48||Tanox||USA||align=right|56.1||align=right|53.4||align=right|(2.6)||align=right|285 |- |align=center|49||ViaCell||USA||align=right|54.4||align=right|14.0||align=right|(21.0)||align=right|282 |- |align=center|50||Indevus Pharmaceuticals||USA||align=right|50.5||align=right|43.2||align=right|-50.6||align=right|279 |- |align=center|51||Medarex||USA||align=right|48.6||align=right|194.5||align=right|(181.7)||align=right|277 |- |align=center|52||NPS Pharmaceuticals||USA||align=right|48.5||align=right|68.4||align=right|(112.7)||align=right|276 |- |align=center|53||Monogram Biosciences||USA||align=right|48.0||align=right|19.0||align=right|(38.7)||align=right|274 |- |align=center|54||Oscient Pharmaceuticals||USA||align=right|46.2||align=right|12.4||align=right|(78.5)||align=right|267 |- |align=center|55||Array BioPharma||USA||align=right|45.0||align=right|33.4||align=right|(39.6)||align=right|263 |- |align=center|56||AEterna Zentaris||Canada||align=right|41.4||align=right|28.7||align=right|33.4||align=right|260 |- |align=center|57||IsoTis||Switzerland||align=right|40.7||align=right|7.7||align=right|(18.5)||align=right|255 |- |align=center|58||Enzo Biochem||USA||align=right|39.8||align=right|7.9||align=right|(15.7)||align=right|255 |- |align=center|59||CuraGen||USA||align=right|39.6||align=right|58.5||align=right|(59.8)||align=right|254 |- |align=center|60||Neurocrine Biosciences||USA||align=right|39.2||align=right|97.7||align=right|(107.2)||align=right|254 |- |align=center|61||MediGene||Germany||align=right|38.4||align=right|26.7||align=right|(8.7)||align=right|248 |- |align=center|62||Life Therapeutics||Australia||align=right|37.6||align=right|0.1||align=right|(31.2)||align=right|245 |- |align=center|63||Inspire Pharmaceuticals||USA||align=right|37.1||align=right|42.5||align=right|(42.1)||align=right|238 |- |align=center|64||CV Therapeutics||USA||align=right|36.8||align=right|135.3||align=right|(274.3)||align=right|233 |- |align=center|65||Cerus||USA||align=right|35.6||align=right|29.5||align=right|(4.8)||align=right|208 |- |align=center|66||SciClone Pharmaceuticals||USA||align=right|32.7||align=right|14.1||align=right|0.7||align=right|197 |- |align=center|67||ImmunoGen||USA||align=right|32.1||align=right|40.9||align=right|(17.8)||align=right|197 |- |align=center|68||Protherics||UK||align=right|30.9||align=right|11.8||align=right|(16.5)||align=right|196 |- |align=center|69||Arena Pharmaceuticals||USA||align=right|30.6||align=right|103.4||align=right|(88.3)||align=right|195 |- |align=center|70||Vernalis||UK||align=right|30.1||align=right|71.7||align=right|(78.2)||align=right|192 |- |align=center|71||Bavarian Nordic||Denmark||align=right|29.5||align=right|19.9||align=right|(27.1)||align=right|191 |- |align=center|72||Xoma||USA||align=right|29.5||align=right|52.1||align=right|(51.8)||align=right|189 |- |align=center|73||GPC Biotech||Germany||align=right|28.5||align=right|81.3||align=right|(80.4)||align=right|180 |- |align=center|74||Micromet||USA||align=right|27.6||align=right|28.3||align=right|0.0||align=right|171 |- |align=center|75||Targacept||USA||align=right|27.5||align=right|21.8||align=right|(1.2)||align=right|170 |- |align=center|76||Carrington Laboratories||USA||align=right|27.4||align=right|5.8||align=right|(7.6)||align=right|166 |- |align=center|77||Acorda Therapeutics||USA||align=right|27.4||align=right|12.1||align=right|(60.0)||align=right|158 |- |align=center|78||Anika Therapeutics||USA||align=right|26.8||align=right|3.6||align=right|4.6||align=right|156 |- |align=center|79||Human Genome Sciences||USA||align=right|25.8||align=right|209.2||align=right|(251.2)||align=right|151 |- |align=center|80||Dusa Pharmaceuticals||USA||align=right|25.6||align=right|6.2||align=right|(31.3)||align=right|150 |- |align=center|81||ZymoGenetics||USA||align=right|25.4||align=right|128.5||align=right|(130.0)||align=right|150 |- |align=center|82||Maxygen||USA||align=right|25.0||align=right|49.1||align=right|(16.5)||align=right|147 |- |align=center|83||Isis Pharmaceuticals||USA||align=right|24.5||align=right|80.6||align=right|(45.9)||align=right|133 |- |align=center|84||Genmab||Denmark||align=right|23.9||align=right|90.6||align=right|(77.4)||align=right|128 |- |align=center|85||Bioniche Life Sciences||Canada||align=right|23.9||align=right|11.6||align=right|(1.0)||align=right|126 |- |align=center|86||Vitrolife||Sweden||align=right|23.2||align=right|3.3||align=right|2.1||align=right|124 |- |align=center|87||Coley Pharmaceutical Group||USA||align=right|20.2||align=right|40.9||align=right|(29.4)||align=right|122 |- |align=center|88||Palatin Technologies||USA||align=right|19.7||align=right|41.0||align=right|(29.0)||align=right|116 |- |align=center|89||Encysive Pharmaceuticals||USA||align=right|19.0||align=right|64.4||align=right|(109.3)||align=right|109 |- |align=center|90||GenVec||USA||align=right|18.9||align=right|29.6||align=right|(19.3)||align=right|95 |- |align=center|91||Medivir Group||Sweden||align=right|18.8||align=right|39.7||align=right|(29.7)||align=right|88 |- |align=center|92||Peptech||Australia||align=right|18.7||align=right|4.6||align=right|3.8||align=right|85 |- |align=center|93||Ambrilia Biopharma||Canada||align=right|17.4||align=right|8.3||align=right|(2.1)||align=right|85 |- |align=center|94||Cytogen||USA||align=right|17.3||align=right|7.3||align=right|(15.1)||align=right|85 |- |align=center|95||Replidyne||USA||align=right|16.0||align=right|38.3||align=right|(34.6)||align=right|79 |- |align=center|96||Sinovac Biotech||China||align=right|15.4||align=right|0.3||align=right|(0.7)||align=right|67 |- |align=center|97||Trimeris||USA||align=right|15.2||align=right|18.3||align=right|7.4||align=right|64 |- |align=center|98||Avanir Pharmaceuticals||USA||align=right|15.2||align=right|29.2||align=right|(62.6)||align=right|64 |- |align=center|99||Adolor||USA||align=right|15.1||align=right|56.7||align=right|(69.7)||align=right|51 |- |align=center|100||Curis||USA||align=right|14.9||align=right|14.6||align=right|(8.8)||align=right|46 |}
See also
References
- ^ DePalma, Angelo (August 2005), "Twenty-Five Years of Biotech Trends", Genetic Engineering News, vol. 25, no. 14, Mary Ann Liebert, pp. 1, 14–23, ISSN 1935-472X, retrieved 2008-08-17
- ^ Top 100 biotechnology companies, MedAdNews, June 2007